Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Carrier Status for P.Gly61glu and P.Arg368his Cyp1b1 Mutations Causing Primary Congenital Glaucoma in Iran Publisher



Heshmati A1 ; Taghizadeh P1 ; Ahmadieh H2 ; Yaseri M3 ; Suri F2 ; Alizadeh M4 ; Dadashzadeh M5 ; Khatami H6 ; Navi MM7 ; Zamanparvar P8 ; Behboudi H9 ; Elahi E1
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Biology, University College of Science, University of Tehran, Tehran, Iran
  2. 2. Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Astaneh Health Center, Guilan, Astaneh, Iran
  5. 5. Rasht Health Center, Guilan, Rasht, Iran
  6. 6. Anzali Health Center, Guilan, Anzali, Iran
  7. 7. Talesh Medical Center, Guilan, Talesh, Iran
  8. 8. Lahijan Medical Center, Guilan, Lahijan, Iran
  9. 9. Department of Ophthalmology, Guilan University of Medical Sciences, Rasht, Iran

Source: Journal of Ophthalmic and Vision Research Published:2021


Abstract

Purpose: To estimate carrier frequencies of CYP1B1 mutations p.Gly61Glu and p.Arg368His, respectively, in Talesh and the east of Guilan province in Iran with a maximum error of 2%. Previously, it was shown that these CYP1B1 mutations may be relatively prevalent in these regions. Methods: Population-based screenings were performed. DNA was extracted from saliva samples of 1036 individuals from Talesh and 3029 individuals from the east of Guilan. P.Gly61Glu and p.Arg368His screenings were performed, respectively, by RFLP and ARMS-based PCR protocols. For confirmation, the DNA of individuals with mutations was sequenced using the Sanger protocol. Results: Nine individuals from Talesh (0.86%; 95%CI: 0.45-1.64%) carried the p.Gly61Glu mutation, and 73 from the east of Guilan (2.41%; 95%CI: 1.91-3.04%) carried p.Arg368His. There was no significant difference in frequencies between urban and rural regions of the various cities, nor among four cities within the east of Guilan. Conclusion: The frequencies of p.Gly61Glu carriers in Talesh and of p.Arg368His carriers in the east of Guilan were within the 95% confidence interval of a previous study based on screenings of fewer individuals. The reliability of the recent estimates is higher, as the confidence interval for p.Gly61Glu decreased from 6.5% to 1.19% and the interval for p.Arg368His decreased from 4% to 1.13%. Based on the new findings, the maximum expected frequency of p.Gly61Glu carriers in Talesh is 1.64%, and of p.Arg368His carriers in the east of Guilan is 3%. The need for performing premarital screenings in the respective cities can be evaluated. © 2021 HESHMATI ET AL. THIS IS AN OPEN ACCESS ARTICLE DISTRIBUTED UNDER THE CREATIVE COMMONS ATTRIBUTION LICENSE | PUBLISHED BY KNOWLEDGE E
Related Docs
1. P.Gly61glu and P.Arg368his Mutations in Cyp1b1 That Cause Congenital Glaucoma May Be Relatively Frequent in Certain Regions of Gilan Province, Iran, Journal of Ophthalmic and Vision Research (2018)
2. Phenotype and Genotype Correlation in Iranian Primary Congenital Glaucoma Patients, Journal of Glaucoma (2016)
3. Mutational Analysis of Cyp1b1 Gene in Iranian Pedigrees With Glaucoma Reveals Known and Novel Mutations, International Ophthalmology (2021)
Experts (# of related papers)
Mehdi Yaseri (2)
Ehsan Aghaei-Moghadam (1)